Effects of Xenon Preconditioning Against Ischemia/Reperfusion Injury and Oxidative Stress in Immature Heart

LI Qian, LIAN Chun-wei, FANG Li-qun.et al

Abstract

To investigate whether xenon preconditioning (PC) could protect immature myocardium against ischemia-reperfusion (I/R) injury in a dose-dependent manner and clarify the role of xenon PC on oxidative stress. Methods Forty-eight isolated perfused immature rabbit hearts were randomly divided into four groups (n=12): The sham group had the hearts perfused continuously for 300 min. In I/R group, the hearts were subjected to 60 min perfusion followed by 60 min ischemia and 180 min reperfusion. In 1 minimum alveolar concentration (MAC) and 0.5 MAC xenon PC groups, the hearts were preconditioned with 1 MAC or 0.5 MAC xenon respectively, following 60 min ischemia and 180 min reperfusion. The cardiac function, myocardial infarct size, mitochondrial structure, superoxide dismutase (SOD) activity and malondialdehyde (MDA) level in each group were determined after reperfusion. Results Compared with I/R group, both 1 MAC and 0.5 MAC xenon preconditioning significantly improved cardiac function (P<0.01), reduced myocardial infarct size (P<0.01) and mitochondrial damage, increased SOD activity and decreased MDA level (P<0.01). There were no differences between 1 MAC group and 0.5 MAC xenon group (P>0.05). Conclusion Xenon preconditioning at 0.5 and 1 MAC produce similar cardioprotective effects against I/R injury in isolated perfused immature heart.

 

Keywords: Immature myocardium, Ischemia/reperfusion injury, Xenon, Preconditioning 

 

Full Text:

PDF


References


Benavidez OJ, Gauvreau K, Del Nido P, et al. Complications and risk factors for mortality during congenital heart surgery admissions. Ann Thorac Surg,2007;84(1): 147-155.

Frassdorf J. De Hert S. Schlack W. Anaesthesia and myocardial ischaemia/reperfusion injury. Br J Anaesth. 2009; 103(1):89-98.

De Hert SG. Anesthetic preconditioning: how important is it in today’s cardiac anesthesia? J Cardiothorac Vase Anesth.2006; 20(4);473-476.

Liu W. Liu Y, Chen H, et al. Xenon preconditioning; molecular mechanisms and biological effects. Med Gas Res, 2013; 3 (1): 3.

Li Q. Lian C, Zhou R. et al. Pretreatment with xenon protected immature rabbit heart from ischaemia/reperfusion injury by opening of the mitoKATP channel. Heart Lung Circ,

2013; 22(4):276-283.

Becker DE, Rosenberg M. Nitrous oxide and the inhalation anesthetics. Anesth Prog,2008;55(4); 124-131.

Preckel В. Sehlack W. Heibel T, et al. Xenon produces minimal haemodynamic effects in rabbits with chronically compromised left ventricular function. Br J Anaesth, 2002; 88 (2) :264-269.

Schriewer JM, Peek CB, Bass J, et al. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J Am Heart Assoc,2013;2(2):e000159. doi:10. 1161/JAHA. 113.000159.

Muller BA, Dhalla NS. Mechanisms of the beneficial actions of ischemic preconditioning on subcellular remodeling in ischemic- reperfused heart. Curr Cardiol Rev,2010;6(4) ;255-264.

Mio Y, Shim YH, Richards P, et al. Xenon preconditioning: the role of prosurvival signaling, mitochondrial permeability transition and bioenergetics in rats. Anesth Analg, 2009; 108 (3) :858-866.

Stoppe C, Fahlenkamp AV, Rex S, et al. Feasibility and safety of xenon compared with sevoflurane anaesthesia in coronary surgical patients;a randomized controlled pilot study. Br J Anaesth,2013; 111(3) :406-416.

Preckel B. Mullenheim J. Moloschavij A, et al. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg, 2000;91(6)j1327-1332.

Weber NC, Toma O, Wolter JI. et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 МАРК. Br J Pharmacol, 2005;144(1):123-132.

Baumert JH, Hein M, Gerets С, et al. The effect of xenon anesthesia on the size of experimental myocardial infarction. A nest h Analg,2007; 105(5): 1200-1206.

Friel JK, Friesen RW, Harding SV, et al. Evidence of oxidative stress in full-term healthy infants. Pediatr Res,2004; 56(6):878-882.

Gill RS, Pelletier JS, LaBossiere J. et al. Therapeutic strategies to protect the immature newborn myocardium during resuscitation following asphyxia. Can J Physiol Pharmacol, 2012;90(6):689-695.

Jia P, Teng J, Zou J, et al. Intermittent exposure to xenon protects against gentamicin-induced nephrotoxicity. PLoS One, 2013;8(5): e64329. doi:10. 1371/journal, pone. 0064329. print 2013.


Refbacks

  • There are currently no refbacks.